drugset / Trial / NCT02428361

Fecal Microbiota Transplant (FMT) for Pouchitis

NCT02428361 ↗

Phase 0 Completed 19 enrolled Najwa Elnachef
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, open label pilot study in which patients with symptoms of acute or chronic pouchitis will receive FMT therapy delivered via pouchoscopy. The investigators hypothesize that FMT is a safe and effective treatment for patients with pouchitis. Our aims our: 1. To determine if symptoms of pouchitis can be successfully treated by Fecal Microbial Transplantation. 2. To determine if endoscopic appearance of ileal pouch improves following treatment by Fecal Microbial Transplantation.

Timeline

Start
2015-05-28
Primary completion
2018-04-09
Completion
2019-03-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Biologically active human fecal material Other / unclassified 250 ml Other

Indications